Cre recombinase is a tyrosine recombinase enzyme derived from the P1 bacteriophage. The enzyme uses a topoisomerase I-like mechanism to carry out site specific recombination events. From Wikipedia
Karolinska Institutet researchers achieve preclinical success in delivering gene editors and protein therapeutics using bioengineered vesicles.